Ouster (OUST)
(Delayed Data from NYSE)
$7.87 USD
-3.01 (-27.67%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $7.89 +0.02 (0.25%) 5:16 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
OUST 7.87 -3.01(-27.67%)
Will OUST be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OUST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OUST
Ouster, Inc. (OUST) Stock Slides as Market Rises: Facts to Know Before You Trade
Ouster, Inc. (OUST) Stock Sinks As Market Gains: What You Should Know
OUST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ouster, Inc. (OUST) Declines More Than Market: Some Information for Investors
Ouster, Inc. (OUST) Declines More Than Market: Some Information for Investors
Are Computer and Technology Stocks Lagging MakeMyTrip Limited (MMYT) This Year?
Other News for OUST
Dow Jumps Over 200 Points; Performance Food Group Shares Gain After Q4 Results
Ouster continues to spiral lower as soft Q2 sales, downbeat guidance weigh on shares
Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz
Ouster falls -22.8%
US Stocks Mixed; Inflation Rate Falls More Than Projected